Neonatal sepsis: Staphylococcus aureus as the predominant pathogen

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Microbiology

Background:

• Bacterial sepsis is a significant cause of neonatal morbidity and mortality.
• Understanding the epidemiology and antimicrobial resistance patterns of neonatal sepsis is crucial for effective management.

Purpose of the Study:

• To investigate the clinical features, causative pathogens, and antibiotic resistance patterns of bacterial sepsis in a cohort of inborn neonates.
• To identify the predominant pathogens and assess their susceptibility to commonly used antibiotics.

Main Methods:

• A prospective study of 96 neonates with blood culture-proven bacterial sepsis from January to June 1997.
• Data collection included clinical presentation, onset of sepsis (early vs. late), and microbiological analysis of blood cultures.
• Antimicrobial susceptibility testing was performed for various antibiotics.

Main Results:

• Lethargy, fever, and respiratory distress were the most common presenting features.
• Staphylococcus aureus (61.5%) was the predominant pathogen, with 66% being methicillin-resistant.
• Other significant pathogens included Klebsiella pneumoniae (21.9%) and Escherichia coli (13.5%).
• High rates of antibiotic resistance were observed, with low sensitivity to ampicillin (19%) and gentamicin (21.6%).

Conclusions:

• Staphylococcus aureus, particularly methicillin-resistant strains, is a major cause of neonatal bacterial sepsis.
• Significant antibiotic resistance complicates the treatment of neonatal sepsis.
• Empirical antibiotic choices should consider local resistance patterns and emerging resistance trends.